Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis

T Schaberg, K Rebhan, H Lode
European Respiratory Journal 1996 9: 2026-2030; DOI: 10.1183/09031936.96.09102026
T Schaberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K Rebhan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H Lode
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 9 no. 10 2026-2030
DOI 
https://doi.org/10.1183/09031936.96.09102026
PubMed 
8902462

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Published online October 1, 1996.

Copyright & Usage 
© 1996

Author Information

  1. T Schaberg,
  2. K Rebhan and
  3. H Lode

Article usage

Article usage: August 2004 to December 2022

AbstractFullPdf
Aug 2004300
Sep 2004208
Oct 20044037
Nov 20044018
Dec 200446029
Jan 200552041
Feb 200550043
Mar 200576046
Apr 200536032
May 200561043
Jun 200586031
Jul 200569055
Aug 200564067
Sep 200534040
Oct 200574051
Nov 200561049
Dec 200535050
Jan 200660027
Feb 200649021
Mar 200673055
Apr 200658034
May 200689033
Jun 200654040
Jul 200663036
Aug 200672049
Sep 2006101075
Oct 2006108072
Nov 2006105076
Dec 200695065
Jan 200788059
Feb 200782051
Mar 2007117057
Apr 2007128071
May 2007100070
Jun 2007100054
Jul 200775070
Aug 2007118053
Sep 200795053
Oct 2007109048
Nov 200777058
Dec 200766046
Jan 2008101044
Feb 200890046
Mar 2008122067
Apr 2008115058
May 2008113054
Jun 2008141059
Jul 200893044
Aug 2008123054
Sep 2008168064
Oct 2008195051
Nov 2008168058
Dec 2008147050
Jan 2009124042
Feb 200990075
Mar 2009112071
Apr 200998056
May 200976039
Jun 200973049
Jul 2009102045
Aug 2009104041
Sep 2009102049
Oct 200969048
Nov 200961046
Dec 200994057
Jan 201090040
Feb 201077048
Mar 2010119093
Apr 201084083
May 2010102061
Jun 201083086
Jul 201070066
Aug 2010730113
Sep 20102100192
Oct 201085095
Nov 20101410128
Dec 2010111099
Jan 201180087
Feb 2011100087
Mar 20111100103
Apr 2011103084
May 201187075
Jun 201194382
Jul 201171055
Aug 201168066
Sep 201189174
Oct 201169086
Nov 201185099
Dec 201173098
Jan 2012690138
Feb 20121020107
Mar 2012820175
Apr 2012860142
May 2012930148
Jun 2012740136
Jul 20121010160
Aug 2012890150
Sep 2012930187
Oct 2012970184
Nov 20121180173
Dec 20121150124
Jan 20131000143
Feb 2013900183
Mar 20131220204
Apr 20131020214
May 2013891196
Jun 2013690187
Jul 2013650183
Aug 2013660132
Sep 2013890137
Oct 2013860143
Nov 2013880127
Dec 2013720162
Jan 2014850175
Feb 2014730191
Mar 2014780221
Apr 2014960256
May 2014880219
Jun 2014600177
Jul 2014850174
Aug 2014860208
Sep 2014102080
Oct 201491053
Nov 2014111085
Dec 201468083
Jan 2015114067
Feb 2015970188
Mar 20151290226
Apr 20151130211
May 20151410175
Jun 2015980157
Jul 2015810115
Aug 20151040132
Sep 20151050113
Oct 2015314098
Nov 2015112088
Dec 2015169069
Jan 20161340107
Feb 2016134064
Mar 2016138080
Apr 2016118075
May 201680063
Jun 201683045
Jul 201680045
Aug 201694069
Sep 2016136061
Oct 2016152051
Nov 2016155082
Dec 201687036
Jan 201771029
Feb 201799044
Mar 2017146047
Apr 2017142047
May 2017103038
Jun 2017109040
Jul 201791090
Aug 2017108035
Sep 2017113058
Oct 20171500122
Nov 20171720103
Dec 201794064
Jan 2018106020
Feb 2018111048
Mar 2018105057
Apr 2018102064
May 201853032
Jun 201864035
Jul 201881039
Aug 201888040
Sep 201880049
Oct 201891083
Nov 201883058
Dec 201856040
Jan 201955042
Feb 201967039
Mar 201965062
Apr 201960054
May 201965051
Jun 201972051
Jul 201972028
Aug 201937021
Sep 201953027
Oct 201962029
Nov 201942034
Dec 201931020
Jan 202049016
Feb 202058039
Mar 202046030
Apr 202034027
May 202080051
Jun 202054044
Jul 202022015
Aug 202043027
Sep 202074079
Oct 202097039
Nov 202063044
Dec 202062033
Jan 202177036
Feb 202158028
Mar 202170025
Apr 202162032
May 202180030
Jun 202166033
Jul 202124025
Aug 202152021
Sep 202147012
Oct 202158043
Nov 202174056
Dec 202143022
Jan 202259026
Feb 202243032
Mar 202263037
Apr 202264055
May 202258041
Jun 202253025
Jul 202263021
Aug 202261018
Sep 202281038
Oct 202269032
Nov 2022103044
Dec 202265027

Altmetrics

PreviousNext
Back to top
Vol 9 Issue 10 Table of Contents
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis
T Schaberg, K Rebhan, H Lode
European Respiratory Journal Oct 1996, 9 (10) 2026-2030; DOI: 10.1183/09031936.96.09102026

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis
T Schaberg, K Rebhan, H Lode
European Respiratory Journal Oct 1996, 9 (10) 2026-2030; DOI: 10.1183/09031936.96.09102026
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Ambulatory management of secondary spontaneous pneumothorax
  • Systematic assessment of respiratory health in illness susceptible athletes
  • Identifying early PAH biomarkers in systemic sclerosis
Show more Original Articles

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society